Management of recurrent viral Hepatitis B and C after liver transplantation

被引：3

作者：

Montalbano M. ^{[1
]}

Neff G.W. ^{[1
]}

机构：

[1] University of Cincinnati, Cincinnati, OH 45267-0595

来源：

Current Gastroenterology Reports | 2006年 / 8卷 / 1期

关键词：

Lamivudine; Adefovir; Tenofovir Disoproxil Fumarate; Liver Transplant Recipient; Sustained Viral Response;

D O I：

10.1007/s11894-006-0065-x

中图分类号：

学科分类号：

摘要：

Liver transplant teams are often faced with the challenges of managing viral recurrence after liver transplantation. Hepatitis C virus (HCV) remains the most challenging viral disease in the transplant community. Strategies to prevent and delay viral recurrence have slowly developed over the past 5 years. Hepatitis B virus (HBV), previously a contra-indication for liver transplantation due to recurrence and cholestasis with allograft failure, is now one of the more favorable indications for liver transplantation as a result of current therapeutic options. This review investigates the up-to-date information on treatment-outcomes for HCV and HBV in the period following liver transplant. Copyright © 2006 by Current Science Inc.

引用

页码：60 / 66

页数：6

共 50 条

[41] Long-term outcome of patients with lamivudine after early cessation of hepatitis B immunoglobulin for prevention of recurrent hepatitis B following liver transplantation
Yuefeng, M.
Weili, F.
Wenxiang, T.
Ligang, X.
Guiling, L.
Hongwei, G.
Wencai, L.
Xiaoguang, W.
Wei, M.
Zhongyi, F.
CLINICAL TRANSPLANTATION, 2011, 25 (04) : 517 - 522
[42] Retransplantation for De Novo Hepatocellular Carcinoma in a Liver Allograft with Recurrent Hepatitis B Cirrhosis 14 Years After Primary Liver Transplantation
Yoshiaki Kita
Göran Klintmalm
Susumu Kobayashi
Katsuhiko Yanaga
Digestive Diseases and Sciences, 2007, 52 : 3392 - 3393
[43] Retransplantation for de novo hepatocellular carcinoma in a liver allograft with recurrent hepatitis b cirrhosis 14 years after primary liver transplantation
Kita, Yoshiaki
Klintmalm, Goean
Kobayashi, Susumu
Yanaga, Katsuhiko
DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (12) : 3392 - 3393
[44] Recommendations for Hepatitis B Immunoglobulin and Antiviral Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation
Akarsu, Mesut
Onem, Soner
Turan, Ilker
Adali, Gupse
Akdogan, Meral
Akyildiz, Murat
Aladag, Murat
Balaban, Yasemin
Danis, Nilay
Dayangac, Murat
Gencdal, Genco
Gokcan, Hale
Sertesen, Elif
Gurakar, Merve
Harputluoglu, Murat
Kabacam, Gokhan
Karademir, Sedat
Kiyici, Murat
Idilman, Ramazan
Karasu, Zeki
TURKISH JOURNAL OF GASTROENTEROLOGY, 2021, 32 (09) : 712 - 719
[45] Pharmacokinetics and efficacy of intravenous or intramuscular hepatitis B immunoglobulins in prophylaxis of hepatitis B after liver transplantation
Marzano, A.
Marengo, A.
Andreone, P.
Volpes, R.
Canova, D.
Cursaro, C.
Riili, A.
Fiorentino, B.
Bacci, M.
Guazzini, S.
Burra, P.
MINERVA MEDICA, 2010, 101 (06) : 373 - 383
[46] Prevention of Recurrence of Hepatitis B Virus Infection after Liver Transplantation
Alberto Sanchez Fueyo
BioDrugs, 2000, 13 : 189 - 194
[47] Prevention of hepatitis B virus reinfection after orthotopic liver transplantation
Zheng-Xin Wang
Hepatobiliary & Pancreatic Diseases International, 2004, (03) : 345 - 348
[48] Recent advances in prevention of hepatitis B recurrence after liver transplantation
Zhi-Feng Xi
Qiang Xia
World Journal of Gastroenterology, 2015, (03) : 829 - 835
[49] Hepatitis B immunoglobulins and/or lamivudine for preventing hepatitis B recurrence after liver transplantation: A systematic review
Chen, Jie
Yi, Liping
Jia, Ji Dong
Ma, Hong
You, Hong
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 (05) : 872 - 879
[50] Hepatitis B infection and liver transplantation
Yoshida, EM
CANADIAN JOURNAL OF GASTROENTEROLOGY, 1997, 11 (05): : 462 - 468

← 1 2 3 4 5 →